• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare

Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare

by Ellie Lampton | Apr 25, 2024

BELLEVUE, Wash. – April 25, 2024 – Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their children....
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care

CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care

by Ellie Lampton | Jan 22, 2024

BELLEVUE, Wash. – January 22, 2024 – Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S. Centers for Disease Control and Prevention (CDC) for privacy-preserving record linkage...
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics

Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics

by Ellie Lampton | Dec 5, 2023

In a study of more than 2.4 million children under the age of 5, new research shows a significant increase in the rate of first-time speech delay diagnoses after July 2020. BELLEVUE, Wash. – December 5, 2023 – Today Truveta announced new research published in JAMA...

Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors

by Ellie Lampton | Dec 4, 2023

BELLEVUE, Wash. – December 4, 2023 – Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors. The Truveta Board of Directors ensures the data and analytics company is operating...
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss

Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss

by Ellie Lampton | Nov 27, 2023

In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15%...
« Older Entries
Next Entries »

Share this


Recent posts

  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
  • Johns Hopkins builds research community to explore new frontiers in health using Truveta Data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.